Generic Ledipasvir-Sofosbuvir Treatment for Adolescents With Chronic Hepatitis C Virus Infection-Reference-Cited by-同舟云学术

Generic Ledipasvir-Sofosbuvir Treatment for Adolescents With Chronic Hepatitis C Virus Infection

Published:2019-07-16 Issue:3 Volume:9 Page:386-389
ISSN:2048-7207
Container-title:Journal of the Pediatric Infectious Diseases Society
language:en
Short-container-title:

Author:

Fouad Hanan M¹²^ORCID,Sabry Magda A²,Ahmed Amal³,Hassany Mohamed⁴,Al Soda Mohamed F⁵,Abdel Aziz Hossam⁶

Affiliation:

1. Department of Pediatrics, Faculty of Medicine, Helwan University, Cairo, Egypt

2. Department of Pediatrics, National Hepatology and Tropical Medicine Research Institute, Cairo, Egypt

3. Department of Biochemistry, and Molecular Biology, National Hepatology and Tropical Medicine Research Institute, Cairo, Egypt

4. Department of Hepatology, National Hepatology and Tropical Medicine Research Institute, Cairo, Egypt

5. Pediatric and Neonatology Department, Ahmed Maher Teaching Hospital, Cairo, Egypt

6. Hepatology Department, Ain Shams University, Cairo, Egypt

Abstract

Abstract We assessed the safety and efficacy of a generic form of ledipasvir-sofosbuvir for the treatment of hepatitis C virus infection in Egyptian adolescents and compared the results with those of treatment with the brand-named form. The generic form resulted in a high response rate, significant improvement in liver function, and mild adverse effects. These results are comparable with those of the brand form at a reduced price.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,General Medicine,Pediatrics, Perinatology, and Child Health

Link

http://academic.oup.com/jpids/article-pdf/9/3/386/33493027/piz041.pdf

Reference13 articles.

1. Hepatocellular carcinoma in 2 young adolescents with chronic hepatitis C;González-Peralta;J Pediatr Gastroenterol Nutr,2009

2. Sustained viral response in genotype 4 chronic hepatitis C virus-infected children and adolescents treated with sofosbuvir/ledipasvir;El-Karaksy;J Pediatr Gastroenterol Nutr,2018

3. The effectiveness of ledipasvir/sofosbuvir in youth with genotype 4 hepatitis C virus: a single Egyptian center study;Fouad;Pediatr Infect Dis J,2019

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of DAA in children and adolescents with chronic HCV infection: A systematic review and meta‐analysis;Liver International;2024-01-31

2. Nationwide hepatitis C virus screening and treatment of adolescents in Egyptian schools;The Lancet Gastroenterology & Hepatology;2022-07

3. Real-Life Experience with Ledipasvir/Sofosbuvir for the Treatment of Chronic Hepatitis C Virus Infection with Genotypes 1 and 4 in Children Aged 12 to 17 Years—Results of the POLAC Project;Journal of Clinical Medicine;2021-09-15

4. High SVR12 With 8-Week Course of Direct-Acting Antivirals in Adolescents and Children With Chronic Hepatitis C: A Comprehensive Analysis;Frontiers in Medicine;2021-06-08

5. Cascade of care for children and adolescents with chronic hepatitis C;World Journal of Gastroenterology;2021-03-28